Works matching IS 00099104 AND DT 2020 AND VI 201 AND IP 2

Results: 11

Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation‐mediated instability using small molecules.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 205, doi. 10.1111/cei.13453
By:
- Haddadi, M.‐H.;
- Negahdari, B.;
- Hajizadeh‐Saffar, E.;
- Khosravi‐Maharlooei, M.;
- Basiri, M.;
- Dabiri, H.;
- Baharvand, H.
Publication type:
Article
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 200, doi. 10.1111/cei.13451
By:
- Venerito, V.;
- Natuzzi, D.;
- Bizzoca, R.;
- Lacarpia, N.;
- Cacciapaglia, F.;
- Lopalco, G.;
- Iannone, F.
Publication type:
Article
IL‐17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 121, doi. 10.1111/cei.13449
By:
- Fletcher, J. M.;
- Moran, B.;
- Petrasca, A.;
- Smith, C. M.
Publication type:
Article
MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 105, doi. 10.1111/cei.13448
By:
- Yacov, N.;
- Kafri, P.;
- Salem, Y.;
- Propheta‐Meiran, O.;
- Feldman, B.;
- Breitbart, E.;
- Mendel, I.
Publication type:
Article
High‐throughput analysis of T cell–monocyte interaction in human tuberculosis.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 187, doi. 10.1111/cei.13447
By:
- Habtamu, M.;
- Abrahamsen, G.;
- Aseffa, A.;
- Andargie, E.;
- Ayalew, S.;
- Abebe, M.;
- Spurkland, A.
Publication type:
Article
Boosting the IL‐22 response using flagellin prevents bacterial infection in cigarette smoke‐exposed mice.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 171, doi. 10.1111/cei.13445
By:
- Koné, B.;
- Pérez‐Cruz, M.;
- Porte, R.;
- Hennegrave, F.;
- Carnoy, C.;
- Gosset, P.;
- Trottein, F.;
- Sirard, J.‐C.;
- Pichavant, M.
Publication type:
Article
Reduced Siglec‐7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 161, doi. 10.1111/cei.13444
By:
- Tao, L.;
- Wang, S.;
- Yang, L.;
- Jiang, L.;
- Li, J.;
- Wang, X.
Publication type:
Article
Clinical and functional consequences of anti‐properdin autoantibodies in patients with lupus nephritis.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 135, doi. 10.1111/cei.13443
By:
- Radanova, M.;
- Mihaylova, G.;
- Ivanova, D.;
- Daugan, M.;
- Lazarov, V.;
- Roumenina, L.;
- Vasilev, V.
Publication type:
Article
Oncolytic adenovirus ORCA‐010 increases the type 1 T cell stimulatory capacity of melanoma‐conditioned dendritic cells.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 145, doi. 10.1111/cei.13442
By:
- López González, M.;
- Ven, R.;
- Haan, H.;
- Eck van der Sluijs, J.;
- Dong, W.;
- Beusechem, V. W.;
- Gruijl, T. D.
Publication type:
Article
Key role of macrophages in tolerance induction via T regulatory type 1 (Tr1) cells.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 222, doi. 10.1111/cei.13440
By:
- Mfarrej, B.;
- Jofra, T.;
- Morsiani, C.;
- Gagliani, N.;
- Fousteri, G.;
- Battaglia, M.
Publication type:
Article
Issue Information.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 2, p. 1, doi. 10.1111/cei.13324
Publication type:
Article